Beactica and KU Leuven secure EUR 2.5 million from the European Innovation Council to advance orphan drug BEA-17 to clinical readiness
UPPSALA, Sweden, Feb. 17, 2026 /PRNewswire/ — Beactica Therapeutics AB, a Swedish precision medicine company, today announced that it, together…
